CBCA’s FY 2023 Report – Examining the Numbers
Client Alert | 1 min read | 01.05.24
The Civilian Board of Contract Appeals (CBCA) recently published its Annual Report for FY 2023, providing statistics regarding the adjudication of appeals between contractors and civilian agencies such as the Department of State, the Department of Veterans Affairs, the General Services Administration, the Department of Transportation, the Department of Agriculture, the Department of the Interior, and the Central Intelligence Agency. According to this year’s report, contractors prevailed in 45% of the appeals decided on the merits, which is much higher than the 21% success rate in 2022. The report also shows that the CBCA’s alternative dispute resolution (ADR) program remains successful—resolving 70% of appeals for which the parties completed ADR. All of this came in the context of a substantial jump in the number of appeals, with 246 new appeals docketed in 2023 compared to 177 in 2022 and 185 in 2021. Click here to view the full CBCA report.
Contacts
Insights
Client Alert | 4 min read | 11.19.26
Since the choppy rollout of the U.S. Small Business Administration’s (SBA) Paycheck Protection Program (PPP) in the early days of the pandemic, the long wake of enforcement actions has followed in waves. First to fall were the bad actors, relying on falsified paperwork for employees and entities and using the loan proceeds to purchase Lamborghinis. Next were those loan recipients who fell victim to the complexities and changes in the loan eligibility requirements, many of which are grounded in the SBA’s existing complex regulations regarding affiliation. While government contractor PPP loan recipients have largely stayed out of the spotlight in reported settlements and False Claims Act (FCA) litigation to date, a recent enforcement action previews that a new wave is coming with government contractors as the target.
Client Alert | 1 min read | 11.19.26
GSA and DHS Launch E-Verify Enforcement Initiative Targeting Contractors
Client Alert | 3 min read | 11.17.26
CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs
Client Alert | 9 min read | 11.17.26
Priorities and Prospects for AI Legislation in the New Congress





